CLINICAL TRIALS UNVEILED:
THE JOURNEY THROUGH SIDE EFFECTS AND SUCCESS

DATE/TIME:
APRIL 18th @ 6:30 P.M. (EST)

LOCATION:
VIRTUAL ROUNDTABLE  

TO SIGN UP, PLEASE COMPLETE THE REGISTRATION FORM BELOW.

GUEST SPEAKERS:

LAURA ESFELLER
Host, “Real Talk on Renal Cancer” Podcast + Stage IV HLRCC Survivor
Laura Esfeller is a dedicated advocate and serves on the boards of JNF and COA. She is the esteemed host of JNF’s “Real Talk On Renal Cancer.” Laura’s personal journey through Stage IV HLRCC gives her a profound understanding of the importance of clinical trials. As a prominent figure in the RCC community, she actively engages with other rare kidney cancer patients, offering support, education, and empowerment to those affected by the disease.

MEGHAN McCARTY GRIFFITH
Vice President, KCCure, and Caregiver to husband, Stage IV ChRCC
Meghan McCarthy Griffith, is a caregiver to her husband, who has undergone clinical trials for Stage IV Chromophobe (ChRCC). As a guest speaker and Vice President of KCCure, her commitment to advocating for kidney cancer patients and their families shines through. With a wealth of experience in caregiving and a profound understanding of the challenges faced by patients navigating through the clinical trials process, Meghan brings invaluable insight and support to the ChRCC community.

SALLY VERSENDAAL
Stage IV Clear Cell RCC Patient 
Sally Versendaal, a Stage IV Clear Cell RCC Patient, brings her journey with stage iv clear cell to the roundtable as a guest speaker. Having undergone multiple surgeries and clinical trials, Sally’s resilience shines through her experiences. Despite facing metastases and treatment side effects, Sally’s journey to NED status for 1.5 years inspires hope and determination in others. 

KATIE COLEMAN
President, Chromophobe and Oncocytic Tumor Alliance (COA) + Stage IV RCC Survivor
Katie Coleman, President of the Chromophobe and Oncocytic Tumor Alliance (COA), is a passionate advocate and well respected in the RCC community. With a focus on advancing research and support for individuals affected by chromophobe and oncocytic tumors, Katie plays a pivotal role in the community. Through her leadership and advocacy efforts, she provides a platform for education, empowerment, and collaboration among patients, caregivers, and healthcare professionals.

GARY CLAYTOR,
CLINICAL TRIALS UNVEILED, MODERATOR
Gary Claytor, a Consultant/Advisor in Healthcare Technology and Stage IV RCC Warrior + Advocate, serves as our esteemed moderator. With his expertise and firsthand experience navigating the challenges of Stage IV RCC, Gary brings invaluable insights and guidance to the roundtable discussion. Join us as Gary leads the conversation, fostering meaningful dialogue.

EVENT REGISTRATION: